from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2899c/fdhD

LFCtreatmentdescriptionclass of inhibitor

-0.136

Amikacinug/mL Amikacintranslation

-1.796

Cap5-10ug/mL Capreomycintranslation

-1.227

Rox10-50 ug/mL Roxithromycintranslation

0.526

SM2-5 ug/mL Streptomycintranslation

-1.400

Tet5-10 ug/mL Tetracyclinetranslation

0.737

Rif0.2-5ug/mL Rifampicintranscription

0.327

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.116

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.994

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.273

CPZ10-50 ug/mL Chlorpromazinerespiration

0.803

Clofazimine10-13 ug/mL Clofaziminerespiration

0.697

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.498

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.077

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.649

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.478

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.559

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.260

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.287

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.027

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.207

KCN5-20 ug/mL Potassium cyaniderespiration

0.503

NaN30.2-2 mM Sodium aziderespiration

0.190

Nigericin50 uM Nigericinrespiration

-0.303

TRC10-150 ug/mL Triclosanrespiration

-0.535

TRZ10-25 ug/mL Thioridazinerespiration

-1.376

Valinomycin0.5-10 uM Valinomycinrespiration

3.628

ZnSO42 mM ZnSO4respiration

-0.521

menadione6-10 ug/mL Menadionerespiration

0.203

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.009

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.347

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.336

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.708

NRP_1Non-replicating persistence stage 1dosRassociated

-0.005

Amp0.2mg/mL AmpicillincellWall

-0.002

Cephalexin20-100 ug/mL CephalexincellWall

0.573

Cerulenin0.32-5 ug/mL CerulenincellWall

0.388

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.482

EMB10-20 ug/mL EthambutolcellWall

0.198

Eta12-40 ug/mL EthionamidecellWall

0.107

INH0.2-0.4 ug/mL IsoniazidcellWall

0.058

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.159

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.585

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.690

BZA0.12 mg/mL BenzamidearomaticAmides

-0.555

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.385

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.016

H2O24 mM hydrogen peroxideDNAdamaging

0.382

Levo10 ug/mL LevofloxacinDNAdamaging

-0.572

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.241

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.131

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.153

UVUV-irradiationDNAdamaging

-0.504

ARP41-4 ug/mL Antitubercular compound ARP4?

0.401

Antimycin12.5-50 ug/mL Antimycin A?

0.575

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.132

PA_110-50 ug/mL Antitubercular compound PA-1?

0.093

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.478

PA8240.2-2 ug/mL PA-824?

0.210

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.493

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.311

Verapamil50 uM Verapamil?

0.669

mercaptoethanol2 mM 2-Mercaptoethanol?

0.681

methoxatin10-20 ug/mL Methoxatin?